Inferior Vena Cava Interruption

Evidence-Based Hematology

Volumn , Issue , 2009, Pages 99-109

  Streiff, Michael B ^a   Hann, Christine L ^a   Ginsberg, Jeff ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Clinical outcomes associated retrievable (optional) vena cava filters; Free floating thrombus and vena cava filter; Inferior vena cava interruption; Patients with vena caval filters undergoing MRI; Presence of vena cava filter indication for indefinite anticoagulation; Vena cava filter placement; Vena cava filters and VTE prophylaxis in orthopedic patients; Vena cava filters used preferentially; Vena caval filters effective in prevention of VTE in high risk trauma patients

Indexed keywords

EID: 70449714593     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300857.ch12     Document Type: Chapter

References (145)

1. Decousus H, Leizorovicz A, Parent F, et al. Aclinical trial of vena caval filters in the prevention of pulmonary embolism in patientswith proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group [see comments]. N Engl J Med. 1998;338(7):409-15.
2. Decousus H, Barral FG, Buchmuller-Cordier A, et al. Eight-year followup of patients with permanent vena cava filters in the prevention of pulmonary embolism:the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416-22.
3. Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev. 2005;19(4):179-202.
4. Crochet DP, Brunel P, Trogrlic S, et al. Long-term follow-up of Vena Tech-LGM filter:predictors and frequency of caval occlusion. J Vasc Interv Radiol. 1999;10(2 Pt 1):137-42.
5. Millward SF, Oliva VL, Bell SD, et al. Gunther Tulip Retrievable vena cava filter:results from the Registry of the Canadian Interventional Radiology Association. J Vasc Interv Radiol. 2001;12(9):1053-58.
6. de Gregorio MA, Gamboa P, Gimeno MJ, et al. The Gunther Tulip retrievable filter:prolonged temporary filtration by repositioning within the inferior vena cava. J Vasc Interv Radiol. 2003;14(10):1259-65.
7. Hoppe H, Nutting CW, Smouse HR, et al. Gunther Tulip filter retrievability multicenter study including CT follow-up:final report. J Vasc Interv Radiol. 2006;17(6):1017-23.
8. Looby S, GivenMF, Geoghegan T, et al. Gunther Tulip retrievable inferior vena caval filters:indications, efficacy, retrieval, and complications. Cardiovasc Intervent Radiol. 2007;30(1):59-65.
9. Yamagami T, Kato T, Hirota T, et al. Evaluation of retrievability of the Gunther Tulip vena cava filter. Cardiovasc Intervent Radiol. 2007;30(2):226-31.
10. Wicky S, Doenz F, Meuwly JY, et al. Clinical experience with retrievable Gunther Tulip vena cava filters. J Endovasc Ther. 2003;10(5):994-1000.
11. PonchonM, Gofette P, Hainaut P. Temporary vena caval filtration:preliminary clinical experience with removable vena caval filters. Acta Clin Belg. 1999;54(5):223-28.
12. Millward SF, Bhargava A, Aquino J Jr. , et al. Gunther Tulip filter:preliminary clinical experience with retrieval. J Vasc Interv Radiol. 2000;11(1):75-82.
13. Allen TL, Carter JL, Morris BJ, et al. Retrievable vena cava filters in trauma patients for high-risk prophylaxis and prevention of pulmonary embolism. Am J Surg. 2005;189(6):656-61.
14. Morris CS, Rogers FB, Najarian KE, et al. Current trends in vena caval filtration with the introduction of a retrievable filter at a level I trauma center. J Trauma. 2004;57(1):32-6.
15. Terhaar OA, Lyon SM, Given MF, et al. Extended interval for retrieval of Gunther Tulip filters. J Vasc Interv Radiol. 2004;15(11):1257-62.
16. HoffWS, Hoey BA, Wainwright GA, Reed JF, Ball DS, Ringold M, et al. Early experience with retrievable inferior vena cava filters in high-risk trauma patients. J AmColl Surg. 2004;199(6):869-74.
17. Offner PJ, Hawkes A, Madayag R, et al. The role of temporary inferior vena cava filters in critically ill surgical patients. Arch Surg. 2003;138(6):591-94.
18. Ray CE Jr. , Mitchell E, Zipser S, et al. Outcomes with retrievable inferior vena cava filters:a multicenter study. J Vasc Interv Radiol. 2006;17(10):1595-604.
19. Meier C, Keller IS, Pfiffner R, et al. Early experience with the retrievable OptEase vena cava filter in high-risk traumapatients. Eur JVascEndovasc Surg. 2006;32(5):589-95.
20. Oliva VL, Szatmari F, Giroux MF, et al. The Jonas study:evaluation of the retrievability of the Cordis OptEase inferior vena cava filter. J Vasc Interv Radiol. 2005;16(11):1439-45.
21. Rosenthal D, Wellons ED, Lai KM, et al. Retrievable inferior vena cava filters:early clinical experience. J Cardiovasc Surg (Torino). 2005;46(2):163-69.
22. Rosenthal D, Wellons ED, Lai KM, et al. Retrievable inferior vena cava filters:initial clinical results. Ann Vasc Surg. 2006;20(1):157-65.
23. Kalva SP, Athanasoulis CA, Fan CM, et al. "Recovery" vena cava filter:experience in 96 patients. Cardiovasc Intervent Radiol. 2006;29(4):559-64.
24. Grande WJ, Trerotola SO, Reilly PM, et al. Experience with the recovery filter as a retrievable inferior vena cava filter. J Vasc Interv Radiol. 2005;16(9):1189-93.
25. Binkert CA, Sasadeusz K, Stavropoulos SW. Retrievability of the recovery vena cava filter after dwell times longer than 180 days. J Vasc Interv Radiol. 2006;17(2 Pt 1):299-302.
26. Asch MR. Initial experience in humans with a new retrievable inferior vena cava filter. Radiology. 2002;225(3):835-44.
27. Mismetti P, Rivron-Guillot K, Quenet S, et al. A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest. 2007;131(1):223-29.
28. Caronno R, Piffaretti G, Tozzi M, et al. Mid-term experience with the ALN retrievable inferior vena cava filter. Eur J Vasc Endovasc Surg. 2006;32(5):596-99.
29. ImbertiD, BianchiM, Farina A, et al. Clinical experiencewith retrievable vena cava filters:results of aprospective observationalmulticenter study. J Thromb Haemost. 2005;3(7):1370-75.
30. Rogers FB, Shackford SR, Wilson J, et al. Prophylactic vena cava filter insertion in severely injured trauma patients:indications and preliminary results. J Trauma. 1993;35(4):637-41.
31. Rogers FB, Shackford SR, Ricci MA, et al. Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism. J AmColl Surg. 1995;180:641-47.
32. Rogers FB, Shackford SR, Ricci MA, et al. Prophylactic vena cava filter insertion in selected high-risk orthopaedic trauma patients. J Orthop Trauma. 1997;11(4):267-72.
33. Rogers FB, Strindberg G, Shackford SR, et al. Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients. Arch Surg. 1998;133:406-11.
34. Sekharan J, Dennis JW, Miranda FE, et al. Long-termfollow-up of prophylactic Greenfield filters in multisystem trauma patients. J Trauma. 2001;51(6):1087-90.
35. Wojcik R, Cipolle MD, Fearen I, et al. Long-term follow-up of trauma patients with a vena caval filter. J Trauma. 2000;49(5):839-43.
36. Van Natta TL, Morris JA Jr. , Eddy VA, et al. Elective bedside surgery in critically injured patients is safe and cost-effective. Ann Surg. 1998;227(5):618-24.
37. McMurtry AL, Owings JT, Anderson JT, et al. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism. JAmColl Surg. 1999;189(3):314-20.
38. Langan EM III, Miller RS, CaseyWJ III, et al. Prophylactic inferior vena cava filters in trauma patients at high risk:follow-up examination and risk/benefit assessment. J Vasc Surg. 1999;30(3):484-48.
39. Leach TA, Pastena JA, Swan KG, et al. Surgical prophylaxis for pulmonary embolism. Am Surg. 1994;60(4):292-95.
40. Khansarinia S, Dennis JW, Veldenz HC, et al. Prophylactic Greenfield filter placement in selected high-risk trauma patients. J Vasc Surg. 1995;22(3):231-35.
41. Gosin JS, Graham AM, Ciocca RG, et al. Efficacy of prophylactic vena cava filters in high-risk trauma patients. AnnVasc Surg. 1997;11(1):100-105.
42. DuperierT, Mosenthal A, SwanKG, et al. Acute complications associated with Greenfield filter insertion in high-risk trauma patients. J Trauma. 2003;54(3):545-49.
43. Zolfaghari D, Johnson B, Weireter LJ, et al. Expanded use of inferior vena cava filters in the trauma population. Surg Annu. 1995;27:99-105.
44. Patton JHJ, Fabian TC, Croce MA, et al. Prophylactic Greenfield filters:acute complications and long-term follow-up [see comments]. J Trauma. 1996;41(2):231-36.
45. Winchell RJ, Hoyt DB, Walsh JC, et al. Risk factors associated with pulmonary embolism despite routine prophylaxis:implications for improved protection. J Trauma. 1994;37(4):600-6.
46. Nunn CR, Neuzil D, Naslund T, et al. Cost-effective method for bedside insertion of vena caval filters in trauma patients [see comments]. J Trauma. 1997;43(5):752-58.
47. Tola JC, Holtzman R, Lottenberg L. Bedside placement of inferior vena cava filters in the intensive care unit. Am Surg. 1999;65(9):833-37.
48. Carlin AM, Tyburski JG, Wilson RF, et al. Prophylactic and therapeutic inferior vena cava filters to prevent pulmonary emboli in trauma patients. Arch Surg. 2002;137(5):521-25.
49. Sing RF, Camp SM, Heniford BT, et al. Timing of pulmonary emboli after trauma:implications for retrievable vena cava filters. J Trauma. 2006;60(4):732-34.
50. Rodriguez JL, Lopez JM, Proctor MC, et al. Early placement of prophylactic vena caval filters in injured patients at high risk for pulmonary embolism. J Trauma. 1996;40(5):797-802.
51. Rosenthal D, McKinsey JF, Levy AM, et al. Use of the Greenfield filter in patients with major trauma. Cardiovasc Surg. 1994;2(1):52-55.
52. Webb LX, Rush PT, Fuller SB, et al. Greenfield filter prophylaxis of pulmonary embolism in patients undergoing surgery for acetabular fracture. J Orthop Trauma. 1992;6(2):139-45.
53. Wilson JT, Rogers FB, Wald SL, et al. Prophylactic vena cava filter insertion in patients with traumatic spinal cord injury:preliminary results. Neurosurgery. 1994;35(2):234-39.
54. Benjamin ME, Sandager GP, Cohn EJ Jr. , et al. Duplex ultrasound insertion of inferior vena cava filters in multitrauma patients. Am J Surg. 1999;178(2):92-97.
55. Greenfield LJ, Proctor MC, Michaels AJ, et al. Prophylactic vena caval filters in trauma:the rest of the story. J Vasc Surg. 2000;32(3):490-97.
56. Karmy-Jones R, JurkovichGJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients:an AAST multicenter study. J Trauma. 2007;62(1):17-24.
57. Antevil JL, Sise MJ, Sack DI, et al. Retrievable vena cava filters for preventing pulmonary embolism in trauma patients:a cautionary tale. J Trauma. 2006;60(1):35-40.
58. White RH, Zhou H, Kim J, Romano PS. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med. 2000;160(13):2033-41.
59. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):204S-33S.
60. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism:a meta-analysis. Ann InternMed. 2003;139(11):893-900.
61. Geerts WH, Code KI, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. NEngl JMed. 1994;331:1601-6.
62. Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism inmoderately to severely injured traumapatients. J Trauma. 2004;56(4):727-31.
63. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335:701-7.
64. Owings JT, Kraut E, Battistella F, et al. Timing of the occurrence of pulmonary embolism in trauma patients. Arch Surg. 1997;132(8):862-66.
65. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism:a population-based case-control study. Arch Intern Med. 2000;160(6):809-15.
66. Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715-22.
67. PrandoniP, LensingAW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patientswith cancerandvenous thrombosis. Blood. 2002;100(10):3484-88.
68. Hutten BA, Prins MH, Gent M, et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio:a retrospective analysis. J Clin Oncol. 2000;18(17):3078-83.
69. Palareti G, Legnani C, Lee A, et al. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Thromb Haemost. 2000;84(5):805-10.
70. Calligaro KD, Bergen WS, Haut MJ, et al. Thromboembolic complications in patients with advanced cancer:anticoagulation versus Greenfield filter placement. Ann Vasc Surg. 1991;5(2):186-89.
71. Cantelmo NL, Menzoian JO, LogerfoFW, et al. Clinical experience with vena caval filters in high-risk cancer patients. Cancer. 1982;50(2):341-44.
72. Lossef SV, Barth KH. Outcome of patients with advanced neoplastic disease receiving vena caval filters. J Vasc Interv Radiol. 19950;6(2):273-77.
73. Greenfield LJ, Proctor MC, Saluja A. Clinical results of Greenfield filter use in patients with cancer. Cardiovasc Surg. 1997;5(2):145-49.
74. Cohen JR, Tenenbaum N, Citron M. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer. Surgery. 1991;109(1):12-15.
75. Hubbard KP, Roehm JOJ, Abbruzzese JL. The Bird's Nest filter:an alternative to long-term oral anticoagulation in patients with advanced malignancies. Am J Clin Oncol. 1994;17(2):115-17.
76. Muchmore JH, Dunlap JN, Culicchia F, et al. Deep vein thrombophlebitis and pulmonary embolism in patients with malignant gliomas. South Med J. 1989;82(11):1352-56.
77. Whitney BA, Kerstein MD. Thrombocytopenia and cancer:use of the Kim-Ray Greenfield filter to prevent thromboembolism. South Med J. 1987;80(10):1246-48.
78. Cohen JR, Grella L, Citron M. Greenfield filter instead of heparin as primary treatmentfor deep venous thrombosis or pulmonary embolism in patients with cancer. Cancer. 1992;70(7):1993-96.
79. Walsh DB, Downing S, Nauta R, et al. Metastatic cancer:a relative contraindication to vena caval filter placement. Cancer. 1987;59:161-63.
80. Rosen MP, Porter DH, Kim D. Reassessment of vena caval filter use in patients with cancer. J Vasc Interv Radiol. 1994;5(3):501-6.
81. Schwarz RE, Marrero AM, Conlon KC, et al. Inferior vena cava filters in cancer patients:indications and outcome. J Clin Oncol. 1996;14(2):652-57.
82. Ihnat DM, Mills JL, Hughes JD, et al. Treatment of patients with venous thromboembolism and malignant disease:should vena cava filter placement be routine?. J Vasc Surg. 1998;28(5):800-7.
83. Jarrett BP, Dougherty MJ, Calligaro KD. Inferior vena cava filters in malignant disease. J Vasc Surg. 2002;36(4):704-7.
84. WallaceMJ, Jean JL, Gupta S, et al. Use of inferior vena caval filters and survival in patients with malignancy. Cancer. 2004;101(8):1902-7.
85. Zerati AE, Wolosker N, Yazbek G, et al. Vena cava filters in cancer patients:experience with 50 patients. Clinics. 2005;60(5):361-66.
86. SchunnC, SchunnGB, Hobbs G, et al. Inferior vena cava filter placement in late-stage cancer. Vasc Endovascular Surg. 2006;40(4):287-94.
87. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349(2):146-53.
88. Norris CS, Greenfield LJ, Herrmann JB. Free-floating iliofemoral thrombus:a risk of pulmonary embolism. Arch Surg. 1985;120:806-8.
89. Voet D, Afschrift M. Floating thrombi:diagnosis and follow-up by duplex ultrasound. Br J Radiol. 1991;64:1010-14.
90. Baldridge ED, Martin MA, Welling RE. Clinical significance of freefloating venous thrombi. J Vasc Surg. 1990;11:62-9.
91. Radomski JS, Jarrell BE, Carabasi RA, et al. Risk of pulmonary embolus with inferior vena cava thrombosis. Am Surg. 1987;53:97-101.
92. Berry RE, GeorgeJE, ShaverWA. Free-floating thrombus:a retrospective analysis. Ann Surg. 1990;211:719-23.
93. Monreal M, Ruiz J, Salvador R, et al. Recurrent pulmonary embolism:a prospective study. Chest. 1989;95:976-79.
94. Pacouret G, Alison D, Pottier J-M, et al. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis:a prospective study. Arch Int Med. 1997;157:305-8.
95. Patel RK, Ramasamy K, Goss D, et al. Ambulatory therapy of patients with free-floating proximal deep vein thrombosis is safe. Thromb Haemost. 2005;94(6):1343-44.
96. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294(15):1909-17.
97. Carmody BJ, Sugerman HJ, Kellum JM, et al. Pulmonary embolism complicating bariatric surgery:detailed analysis of a single institution's 24-year experience. J AmColl Surg. 2006;203(6):831-37.
98. Poulose BK, GriffinMR, ZhuY, et al. National analysis of adverse patient safety for events in bariatric surgery. Am Surg. 2005;71(5):406-13.
99. Gargiulo NJ III, Veith FJ, Lipsitz EC, et al. Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg. 2006;44(6):1301-5.
100. Schuster R, Hagedorn JC, Curet MJ, et al. Retrievable inferior vena cava filters may be safely applied in gastric bypass surgery. Surg Endosc. 2007;21:2277-9.
101. Ferrell A, Byrne TK, Robison JG. Placement of inferior vena cava filters in bariatric surgical patients-possible indications and technical considerations. Obes Surg. 2004;14(6):738-43.
102. Piano G, Ketteler ER, Prachand V, et al. Safety, feasibility, and outcome of retrievable vena cava filters in high-risk surgical patients. J Vasc Surg. 2007;45(4):784-88.
103. Keeling WB, Haines K, Stone PA, et al. Current indications for preoperative inferior vena cava filter insertion in patients undergoing surgery for morbid obesity. Obes Surg. 2005;15(7):1009-12.
104. Prystowsky JB, MoraschMD, Eskandari MK, et al. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery. 2005;138(4):759-63.
105. Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of lowmolecularweight heparin in bariatric surgery. Obes Surg. 2002;12(1):19-24.
106. Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery:findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368-74.
107. Johnson SP, Raiken DP, Grebe PJ, et al. Single institution prospective evaluation of the over-the-wire Greenfield vena caval filter. J Vasc Interv Radiol. 1998;9(5):766-73.
108. Teitelbaum GP, Bradley WG Jr. , Klein BD. MR imaging artifacts, ferromagnetism, and magnetic torque of intravascular filters, stents, and coils. Radiology. 1988;166(3):657-64.
109. Watanabe AT, Teitelbaum GP, Gomes AS, et al. MRimaging of the bird's nest filter. Radiology. 1990;177(2):578-79.
110. Teitelbaum GP, Ortega HV, Vinitski S, et al. Low-artifact intravascular devices:MR imaging evaluation. Radiology. 1988;168(3):713-19.
111. Grassi CJ, Matsumoto AH, Teitelbaum GP. Vena caval occlusion after Simon nitinol filter placement:identification with MR imaging in patients with malignancy. J Vasc Interv Radiol. 1992;3(3):535-39.
112. Kim D, Edelman RR, Margolin CJ, et al. The Simon nitinol filter:evaluation by MR and ultrasound. Angiology. 1992;43(7):541-48.
113. Kiproff PM, Deeb ZL, Contractor FM, et al. Magnetic resonance characteristics of the LGMvena cava filter:technical note. Cardiovasc Intervent Radiol. 1991;14(4):254-55.
114. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. NEngl J Med. 2004;350(22):2257-64.
115. Jamieson SW, Nomura K. Indications for and the results of pulmonary thromboendarterectomy for thromboembolic pulmonary hypertension. Semin Vasc Surg. 2000;13(3):236-44.
116. Bonderman D, Skoro-Sajer N, Jakowitsch J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007;115(16):2153-58.
117. Mo M, Kapelanski DP, Mitruka SN, et al. Reoperative pulmonary thromboendarterectomy. Ann Thorac Surg. 1999;68(5):1770-76.
118. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119(1 Suppl):132S-75S.
119. White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998;158(14):1525-31.
120. Bicalho PS, Hozack WJ, Rothman RH, et al. Treatment of early symptomatic pulmonary embolism after total joint arthroplasty. J Arthroplasty. 1996;11(5):522-24.
121. EmersonRHJ, Cross R, HeadWC. Prophylacticandearly therapeutic use of the Greenfield filter in hip and knee joint arthroplasty. J Arthroplasty. 1991;6(2):129-35.
122. Vaughn BK, Knezevich S, Lombardi AVJ, et al. Use of the Greenfield filter to prevent fatal pulmonary embolism associated with total hip and knee arthroplasty. J Bone Joint Surg Am. 1989;71(10):1542-48.
123. Woolson ST, HarrisWH. Greenfield vena caval filter for management of selected cases of venous thromboembolic disease following hip surgery. Clin Orthoped Rel Res. 1986;204:201-6.
124. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997;336(21):1506-11.
125. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum:a 30-year population-based study. Ann Intern Med. 2005;143(10):697-706.
126. Cerneca F, Ricci G, Simeone R. Coagulation and fibrinolysis changes in normal pregnancy:increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol. 1997;73(1):31-36.
127. Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost. 1998;79(6):1166-70.
128. Gates S. Thromboembolic disease in pregnancy. Curr Opin Obstet Gynecol. 2000;12(2):117-22.
129. Bates SM, Ginsberg JS. How we manage venous thromboembolism during pregnancy. Blood. 2002;100(10):3470-78.
130. Aburahma AF, Boland JP. Management of deep vein thrombosis of the lower extremity in pregnancy:a challenging dilemma. Am Surg. 1999;65(2):164-67.
131. AburahmaAF, MullinsDA. Endovascular caval interruption inpregnant patients with deep vein thrombosis of the lower extremity. J Vasc Surg. 2001;33(2):375-78.
132. Banfield PJ, Pittam M, Marwood R. Recurrent pulmonary embolism in pregnancy managed with the Greenfield vena caval filter. Int J Gynaecol Obstet. 1990;33(3):275-78.
133. Narayan H, Cullimore J, Krarup K, et al. Experience with the cardial inferior vena cava filter as prophylaxis against pulmonary embolism in pregnant women with extensive deep venous thrombosis. Br J Obstet Gynaecol. 1992;99(8):637-40.
134. Neill AM, Appleton DS, Richards P. Retrievable inferior vena caval filter for thromboembolic disease in pregnancy [see comments]. Br J Obstet Gynaecol. 1997;104(12):1416-18.
135. Owen RJ, Krarup KC. Case report:the successful use and removal of the Gunther Tulip inferior vena caval filter in pregnancy. Clin Radiol. 1997;52(3):241-43.
136. Bates SM, Greer IA, Hirsh J, et al. Use of antithrombotic agents during pregnancy:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):627S-44S.
137. Arnesen H, Hoiseth A, Ly B. Streptokinase of heparin in the treatment of deep vein thrombosis:follow-up results of a prospective study. Acta Med Scand. 1982;211(1-2):65-8.
138. Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis:an interim report of a prospective trial. Br J Surg. 1979;66(12):838-43.
139. ElsharawyM, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. a randomised clinical trial. Eur J Vasc Endovasc Surg. 2002;24(3):209-14.
140. Grossman C, McPherson S. Safety and efficacy of catheter-directed thrombolysis for iliofemoral venous thrombosis. AJR Am J Roentgenol. 1999;172(3):667-72.
141. Mewissen MW, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis:report of a national multicenter registry. Radiology. 1999;211(1):39-49.
142. Grimm W, Schwieder G, Wagner T. Fatal pulmonary embolism in venous thrombosis of the leg and pelvis during lysis therapy. Dtsch Med Wochenschr. 1990;115(31-32):1183-87.
143. Martin M, Eickerling B. Todliche lungenembolie unter ultrahochdosierter Streptokinase-Behandlung. Dtsch Med Wochenschr. 1990;115(47):1812.
144. Lorch H, Welger D, Wagner V, et al. Current practice of temporary vena cava filter insertion:a multicenter registry. J Vasc Interv Radiol. 2000;11(1):83-8.
145. ProtackCD, Bakken AM, Patel N, et al. Long-termoutcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg. 2007;45(5):992-97.